Pharmanutra S.p.A. Profit Margin

The latest profit margin for PHN.MI is 14.52% as of June 2026. That compares with 13.76% in the prior-year period — up 5.5% year over year. That is above the sector sector average of 13.2%. Investors often review this figure alongside Pharmanutra S.p.A.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PHN.MI's profit margin moved from 13.76% to 14.52% — a 5.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pharmanutra S.p.A.'s valuation or profitability profile.

Against its sector companies, PHN.MI currently prints 14.52% for profit margin, while the sector average sits near 13.2%. That is roughly 10.0% above the sector mean. Large gaps often invite a closer look at Pharmanutra S.p.A.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Pharmanutra S.p.A. converts resources into returns. At 14.52%, PHN.MI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 13.76% in the prior-year period — up 5.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PHN.MI's profit margin (14.52%), review year-over-year change from 13.76%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.